Fubotv earnings beat by $0.10, revenue topped estimates
Jesse Neri, Senior Vice President of Finance and CFO at Rockwell Medical , Inc. (NASDAQ:RMTI), recently sold 886 shares of the company’s common stock. The transaction, executed on April 1, 2025, was conducted under a pre-established Rule 10b5-1 trading plan. The shares were sold at a price of $1.10 each, amounting to a total sale value of $974. Following this transaction, Neri retains ownership of 30,000 shares in the company. The sale comes as RMTI trades near its 52-week low of $1.06, with analyst targets ranging from $3 to $5 per share. According to InvestingPro analysis, the company maintains strong financial health with a current ratio of 2.63, indicating solid liquidity. Discover 14 additional key insights about RMTI and access comprehensive analysis through InvestingPro’s detailed research reports.
In other recent news, Rockwell Medical announced its fourth-quarter and full-year 2024 financial results, exceeding revenue expectations with $101.5 million, surpassing the forecast of $99.4 million. The company also reported an earnings per share of $0.04, beating the forecast of $0. Despite these positive results, Rockwell Medical anticipates a challenging year ahead with a projected 2025 revenue range of $65-70 million. This decrease is attributed to the company’s largest customer transitioning to an alternative supplier, which is expected to result in a $34 million revenue loss compared to 2024.
To address this anticipated decline, Rockwell Medical is actively seeking to reduce expenses and explore new business opportunities. Analysts at H.C. Wainwright have responded to these developments by lowering the price target for Rockwell Medical’s stock from $7.00 to $3.00, while maintaining a Buy rating. The firm’s decision reflects the expected impact on the company’s revenue growth in the near and medium term. Despite the revenue challenges, Rockwell Medical continues to focus on expanding into international markets and launching new products, which the company believes will offer growth opportunities in the future.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.